In breast cancer, LINE-1 hypomethylation is notably associated with the HER-2-enriched subtype [46] and correlates with tumor histological grade, indicating a potential role in tumor progression and prognosis [38,40,43,47,48]. This evidence concerns the gene ERBB2 and neoplasm.